Stock Analysis
- Hong Kong
- /
- Medical Equipment
- /
- SEHK:1858
Beijing Chunlizhengda Medical Instruments First Quarter 2024 Earnings: EPS: CN¥0.14 (vs CN¥0.15 in 1Q 2023)
Beijing Chunlizhengda Medical Instruments (HKG:1858) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥221.9m (down 9.9% from 1Q 2023).
- Net income: CN¥55.1m (down 1.4% from 1Q 2023).
- Profit margin: 25% (up from 23% in 1Q 2023). The increase in margin was driven by lower expenses.
- EPS: CN¥0.14 (down from CN¥0.15 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Beijing Chunlizhengda Medical Instruments Earnings Insights
Looking ahead, revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Medical Equipment industry in Hong Kong.
Performance of the Hong Kong Medical Equipment industry.
The company's shares are up 9.4% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 1 warning sign for Beijing Chunlizhengda Medical Instruments that you need to be mindful of.
Valuation is complex, but we're helping make it simple.
Find out whether Beijing Chunlizhengda Medical Instruments is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1858
Beijing Chunlizhengda Medical Instruments
An orthopedic medical device company, engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People’s Republic of China.
Flawless balance sheet and undervalued.